Indefinite Delivery Contract 75N91019D00029
Award Date
8/31/19
Last Date to Order
8/30/24
Federal Agency
National Cancer Institute
Awardee
The Broad Institute, Inc.
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business. The purpose of this $149.17 million multiple-award IDC is to acquire genome characterization center (GCC) services for comprehensive sequencing and array platforms, including whole exome sequencing, to support NCI's cancer genomics research...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian federal agency, to Infinity Biologix LLC dba Sampled Division, a for-profit limited liability company. The contract, valued at up to $149,173,285, is for genome characterization center (GCC) services consisting of large-scale, high-resolution, and comprehensive sequencing and array platforms, including whole exome sequencing. The GCCs will receive cancer biomaterials and associated data from...
This Indefinite Delivery Contract was awarded by the National Cancer Institute (NCI), a civilian agency, to New York Genome Center, Inc. (Nygc) with a ceiling value of $149,173,285. The purpose of this IDIQ contract is to acquire genome characterization services consisting of large-scale, high-resolution, and comprehensive sequencing and array platforms including whole exome sequencing to support NCI's genomics research initiatives. The contract has a 5-year period of performance starting in...
The National Institutes of Health (NIH) awarded a multiple-award indefinite delivery contract (IDC) with a $149 million ceiling to The Broad Institute, Inc. under the Brain Initiative Cell Atlas Network (BICAN) Sequencing Core program. This IDC supports the BRAIN Initiative's efforts to map cell atlases of the brain, with The Broad Institute providing large-scale DNA sequencing, data analysis, and other scientific services. Specific task orders issued under this IDC include a $61.5 million award...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to the British Columbia Cancer Agency Branch, a Canadian non-profit organization, to procure tissue samples and data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program. The $16,000 firm fixed-price delivery order was issued on September 20, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase contract, which does not have a set-aside designation....
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian federal agency under the Department of Health and Human Services, to the Ontario Institute for Cancer Research (OICR), a non-profit research organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The contract has a total ceiling value of $784,000 and a period of performance from...
The National Cancer Institute (NCI), part of the National Institutes of Health within the Department of Health and Human Services, has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Azenta US Inc., doing business as Brooks Life Sciences Inc., for the provision of genomic characterization services to support the NCI's Center for Cancer Genomics research programs. The IDIQ contract has a $49,832,452 ceiling value and a period of performance from August 31, 2019 through...
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated. The $315,000 contract provides tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program, with a period of performance through March 31, 2015. The contract is funded through the American Recovery and Reinvestment Act (ARRA) and does not have a small...
This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to provide Biomedical Information Management and Analytic Support Services. The multiple award IDV has a potential value of $148 million over five years. Task orders issued to date include $1.56 million for data analytics, statistical analysis and bioinformatics support for genome-wide association studies under cost plus fixed fee pricing to...
This Indefinite Delivery Contract (IDC) with ID 75N91018D00009 was awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to the Public Health Institute (PHI), a non-profit organization. The $500,000,000 contract, with a period of performance ending on April 30, 2028, is part of the NCI's Surveillance Epidemiology and End Results (SEER) program and does not have a set-aside designation. Under this IDC, PHI...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 75N91019D00029-75N91020F00001 | The Broad Institute, Inc. | $2.7m | 9/1/20 | 8/31/25 | 5/22/25 | |
Delivery Order 75N91019D00029-75N91021F00001 | The Broad Institute, Inc. | $3.9m | 9/10/21 | 9/9/26 | 5/28/25 | |
Delivery Order 75N91019D00029-75N91019F00129 | The Broad Institute, Inc. | $19.6m | 8/31/19 | 8/30/24 | 3/3/25 |